Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

41.08
Delayed Data
As of 4:00pm ET
 +1.59 / +4.03%
Today’s Change
31.08
Today|||52-Week Range
80.25
-46.50%
Year-to-Date
Roche Gets FDA Nod for Emergency Use of Zika Virus Test
Aug 29 / Zacks.com - Paid Partner Content
Roche Launches Accu-Chek Blood Glucose Monitoring System
Aug 23 / Zacks.com - Paid Partner Content
Novartis (NVS) Reports Positive Phase III Results on MS Drug
Aug 26 / Zacks.com - Paid Partner Content
Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults
Aug 22 / Zacks.com - Paid Partner Content
Mallinckrodt to Divest Nuclear Imaging Business for $690M
Aug 25 / Zacks.com - Paid Partner Content
Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Aug 19 / Zacks.com - Paid Partner Content
Cempra's Application for Pneumonia Drug Validated in EU
Aug 24 / Zacks.com - Paid Partner Content
Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan
Aug 19 / Zacks.com - Paid Partner Content
Novartis Licenses Anti-PCSK9 Antibody to Cyon Therapeutics
Aug 24 / Zacks.com - Paid Partner Content
OncoGenex Down on Poor Phase III Data on Lead Cancer Drug
Aug 17 / Zacks.com - Paid Partner Content